FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Clears Varian Microwave Ablation

FDA clears a Varian 510(k) for its IntelliBlate microwave ablation system, intended for ablating soft tissue.

latest-news-card-1
Human Drugs

Require Nasal Spray Food Studies: Aquestive

Aquestive asks FDA not to approve any nasal sprays that do not submit food effect studies as part of their application.

latest-news-card-1
Human Drugs

Amazon, Walmart Illegally Sell Chemical Peels

FDA warns Amazon and Walmart they are introducing unapproved chemical peel products into interstate commerce.

latest-news-card-1
Human Drugs

FDA Denies Public Citizen Tramadol Petition

Citing a lack of legal authority, FDA denies a Public Citizen 2019 petition asking it to join with the Drug Enforcement Administration to reschedule t...

latest-news-card-1
Human Drugs

Novartis sNDA for Scemblix Expanded Use

FDA accepts for priority review a Novartis supplemental NDA for Scemblix (asciminib) for the drugs expanded use in treating newly diagnosed adult pati...

latest-news-card-1
Federal Register

Pharmacy Compounding Panel Renewed

Federal Register notice: FDA renews its Pharmacy Compounding Advisory Committee for an additional two years.

latest-news-card-1
Federal Register

23 No-Longer-Marketed ANDAs Withdrawn

Federal Register notice: FDA withdraws approval of 23 ANDAs from multiple applicants after they notified the agency that the products are no longer be...

latest-news-card-1
Human Drugs

AstraZeneca Reports Favorable Calquence Data

AstraZeneca says data from its Phase 3 AMPLIFY trial showed that Calquence (acalabrutinib) in combination with venetoclax showed favorable progression...

latest-news-card-1
Human Drugs

Kaleo Social Media Post Runs Afoul of FDA

FDA cites a Kaleo social media post about Auvi-Q (epinephrine injection) because it presented benefit information but failed to include any risk infor...

latest-news-card-1
Human Drugs

Carie Boyd Pharma Hit with FDA-483

FDA issues Carie Boyd Pharmaceuticals a six-observation Form FDA-483 after inspecting the firms Irving,TX outsourcing facility last month.